Wall St Price Targets

SRTA Price Forecast
Based on 6 analysts

+48% Upside
from $6.05 today

Strata Critical Medical Inc (SRTA)’s 12-month stock price forecast through November 2027 has a consensus target of $8.93, implying 48% upside. The forecast is based on price targets from 6 Wall Street analysts.

SRTA Analyst Rating
Based on 4 analysts

avg. 5 of 5
Strong buy
4 100%
Buy
0 0%
Hold
0 0%
Sell
0 0%
Strong sell
0 0%

Analysts rate SRTA Strong buy, with 4 of 4 recommending Buy or Strong buy.

Strata Critical Medical Inc Competitors:
Price Targets

Financial Estimates

Past growth per year

Average annual growth cannot be calculated for these periods.

Explore analyst estimates, growth and forecast ranges.

Reported Lowest–highest estimate

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is SRTA's stock price target?
Price Target
8.93 USD

According to Wall Street analysts, the average 1-year price target for SRTA is 8.93 USD with a low forecast of 8.08 USD and a high forecast of 13.65 USD.

What is the Revenue forecast for Strata Critical Medical Inc?
Projected CAGR
30%

Over the last 3 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 2 years is 30%.

What is the Gross Profit forecast for Strata Critical Medical Inc?
Projected CAGR
34%

Over the last 3 years, the compound annual growth rate for Gross Profit has been 20%. The projected CAGR for the next 2 years is 34%.

What is the Net Income forecast for Strata Critical Medical Inc?
Projected CAGR
-94%

The compound annual growth rate for Net Income over the next 2 years is -94%.

Back to Top